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Abstract
Background: Intradermal injection of capsaicin into the hind paw of rats induces spinal cord
central sensititzation, a process in which the responsiveness of central nociceptive neurons is
amplified. In central sensitization, many signal transduction pathways composed of several cascades
of intracellular enzymes are involved. As the phosphorylation state of neuronal proteins is strictly
controlled and balanced by the opposing activities of protein kinases and phosphatases, the
involvement of phosphatases in these events needs to be investigated. This study is designed to
determine the influence of serine/threonine protein phosphatase type 2A (PP2A) on the central
nociceptive amplification process, which is induced by intradermal injection of capsaicin in rats.
Results: In experiment 1, the expression of PP2A protein in rat spinal cord at different time points
following capsaicin or vehicle injection was examined using the Western blot method. In
experiment 2, an inhibitor of PP2A (okadaic acid, 20 nM or fostriecin, 30 nM) was injected into the
subarachnoid space of the spinal cord, and the spontaneous exploratory activity of the rats before
and after capsaicin injection was recorded with an automated photobeam activity system. The
results showed that PP2A protein expression in the spinal cord was significantly upregulated
following intradermal injection of capsaicin in rats. Capsaicin injection caused a significant decrease
in exploratory activity of the rats. Thirty minutes after the injection, this decrease in activity had
partly recovered. Infusion of a phosphatase inhibitor into the spinal cord intrathecal space
enhanced the central sensitization induced by capsaicin by making the decrease in movement last
longer.
Conclusion: These findings indicate that PP2A plays an important role in the cellular mechanisms
of spinal cord central sensitization induced by intradermal injection of capsaicin in rats, which may
have implications in clinical pain therapy.
Introduction
The phosphorylation and dephosphorylation of proteins
are reversible processes, catalyzed by opposing protein
kinases and phosphatases (PP), respectively. Such reac-
tions seem to modulate the function of several proteins
involved in synaptic transmission, including voltage-
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gated and ligand-gated channels, ionotropic and metabo-
tropic neurotransmitter receptors, proteins involved in
neurotransmitter release and transport, and cytoskeletal
proteins [1-8]. These proteins play an important role in
the control of many intracellular events. Serine/threonine
protein phosphatase, which dephosphorylates serine and
threonine protein residues, can be divided into PP1,
PP2A, PP2B, PP2C, PP4, PP5, PP6 and PP7 [2]. Among
them, PP2A is the most abundant phosphatase in mam-
malian cells and is expressed at high levels in the central
nervous system [1,6]. PP2A regulates many fundamental
cellular processes, such as cell division, signal transduc-
tion, gene expression, development, the cell cycle, exocy-
tosis, and apoptosis [2,6,9-12]. The function of this
protein phosphatase can be inhibited by several drugs,
such as okadaic acid (OA), which is a cell permeable mol-
ecule that inhibits PP2A in vitro at much lower concentra-
tions than PP1 (1:100) [13,14]. Fostriecin is another cell
permeable protein phosphatase inhibitor. Since this mol-
ecule is on the order of 104–105 times more selective for
PP2A than PP1, fostriecin is the most selective inhibitor
known for any member of this class of phosphatases [13].
Strong noxious stimulation of peripheral tissues, such as
intradermal injection of capsaicin into the hind paw of
rats, induces spinal cord central sensititzation, a process in
which an amplified responsiveness of central nociceptive
neurons is found. It has been verified that signal transduc-
tion pathways involved in central sensitization are com-
posed of several cascades of enzymes that activate
intracellular protein kinases. As the phosphorylation state
of neuronal proteins is strictly controlled and balanced by
the opposing activities of protein kinases and phos-
phatases, the involvement of phosphatases in these events
needs to be investigated.
In the present study, we evaluated the effects of noxious
stimulation of peripheral tissues on the expression of
PP2A protein in the spinal cord of rats. We also tested the
effects of two inhibitors of PP2A, okadaic acid and fos-
triecin, on the induction and maintenance of central sen-
sitization induced by capsaicin injection, using the
spontaneous exploratory activity test. The inhibitors were
administered through an intrathecal catheter to detect the
role of the spinal cord in changes in these behaviors.
Results
Increased expression of PP2A in spinal cord after capsaicin 
injection
To determine if the expression of PP2A protein in the lum-
ber spinal cord of rats changes following noxious stimula-
tion with intradermal injection of capsaicin, a Western
blot analysis was performed. The Western blots in Fig. 1A
show that the expression of PP2A in the lumbar segments
(L3-L6) of the spinal cord tissue was detected at around 36
kDa. The relative density of immunoblots of PP2A protein
from rat spinal cord tissue after intradermal vehicle or
capsaicin injection is summarized in Fig 1B. Statistical
analysis of these data showed that intradermal injection
of capsaicin causes a significant increase in expression of
PP2A protein in a time-dependent manner compared
with the vehicle injection group. The PP2A protein started
to increase in spinal cord tissue by 15 min, peaked at 30
min, and the increase continued for more than 60 min
following intradermal injection of capsaicin. Vehicle
injection did not result in an obvious increase in the
expression of PP2A protein in the lumbosacral spinal
cord. In addition, the expression of β-actin did not show
any significant change in any of the groups.
The effect of intrathecal catheter implantation on 
exploratory behavior
The spontaneous activity of rats and all six behavioral
parameters were examined both before and 5 days after
intrathecal implantation of a catheter. Fig. 2 demonstrates
that motor function was not impacted by the intrathecal
injection procedure. Compared to the naïve rats, the gen-
eral exploratory behaviors of rats with intrathecal implan-
Expression of PP2A protein in the spinal cord at 5, 15, 30, 60,  and 90 minutes following vehicle or capsaicin injection in the  periphery Figure 1
Expression of PP2A protein in the spinal cord at 5, 15, 30, 60, 
and 90 minutes following vehicle or capsaicin injection in the 
periphery. (A) Immunoreactive bands of rat spinal cord tissue 
(L3–L6) against PP2A antibody at 5, 15, 30, 60, and 90 min-
utes after capsaicin or vehicle injection; the lower row shows 
the bands produced by the antibody to β-actin as a loading 
control at the same times. (B) Bar graph summarizing the rel-
ative density of the immunoblots of rat spinal cord tissue 
(L3–L6) with the PP2A antibody to that of β-actin at 5, 15, 
30, 60, and 90 minutes after capsaicin or vehicle injection. 
Open bar: vehicle injection, filled bar: capsaicin injection. N = 
6 in each group; the relative densities are expressed as mean 
± SEM. *p < 0.05.
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Exploratory activity during a consecutive period of 45 minutes (9 intervals, 5 min/interval) after introduction of the rat into the  novel chamber Figure 2
Exploratory activity during a consecutive period of 45 minutes (9 intervals, 5 min/interval) after introduction of the rat into the 
novel chamber. Compared to naïve rats (n = 14), intrathecal catheter implanted rats (n = 14) do not have significant alterations 
in exploratory activity. Rats with intradermal injection of capsaicin (1%, 50 µl) (n = 6) demonstrated a reduction of exploratory 
activity, including decreased number of photobeams broken (A), shortened travel distance (B), decreased active time (C), 
increased resting time (D), shortened rearing time (E), and decreased number of rearing events (F). The capsaicin-injected 
group was compared to the other two groups. *p < 0.05.
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tation, such as the total activity (1874 ± 146), distance
traveled (668 ± 29), and length of active time (1675 ± 42)
in consecutive 45-minute intervals (n = 13) were not sig-
nificantly different. In addition, no significant decreases
Effect of the PP2A inhibitor, okadaic acid (OA, 20 nM) on exploratory activity of rats during a consecutive period of 45 minutes  (9 intervals, 5 min/interval) Figure 3
Effect of the PP2A inhibitor, okadaic acid (OA, 20 nM) on exploratory activity of rats during a consecutive period of 45 minutes 
(9 intervals, 5 min/interval). Compared to the intrathecal catheter implanted rats (n = 14), pretreatment with OA through an 
intrathecal catheter (n = 7) did not produce significant alterations in exploratory activity.
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Effects of two PP2A inhibitors, OA and fostriecin, on the reduced exploratory activity of rats initiated by capsaicin injection  during a consecutive period of 45 minutes (9 intervals, 5 min/interval) Figure 4
Effects of two PP2A inhibitors, OA and fostriecin, on the reduced exploratory activity of rats initiated by capsaicin injection 
during a consecutive period of 45 minutes (9 intervals, 5 min/interval). Compared to the rats in the ACSF-pretreated group (n 
= 7), the rats with either OA (20 nM, n = 7) or fostriecin (30 nM, n = 5) pretreatment displayed significantly decreased explor-
atory activity, including a decreased number of photobeams broken (A), shortened distance traveled (B), decreased active time 
(C), increased resting time (D), shortened rearing time (E), and decreased number of rearing events (F). *p < 0.05.
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were found in other parameters. On the average, rearing
events and rearing times of 267 ± 16/45 min and 451 ±
77/45 min were found in naïve rats; they were 221 ± 19/
45 min and 424 ± 61/45 min, respectively, in implanted
rats.
Intradermal injection of capsaicin changes exploratory 
behavior of rats
After noxious stimulation by intradermal injection of cap-
saicin in the left hind paw of rats that were implanted
intrathecally with a catheter, spontaneous exploratory
activity was severely affected compared to the naïve and
intrathecally implanted rats (Fig. 2). Total activity greatly
decreased from 1874 ± 147 to 1022 ± 81, and distance
traveled decreased significantly from 668 ± 29 to 495 ± 9
in consecutive 45-minute intervals (Fig. 2A and 2B).
Active time decreased from 1675 ± 42 to 1401 ± 25,
whereas resting time increased from 1025 ± 42 to 1299 ±
25 (Fig. 2C and 2D). Rearing activity was also significantly
impacted by capsaicin injection. Rearing time decreased
greatly from 424 ± 61 to 206 ± 6, and rearing events
decreased from 221 ± 19 to 116 ± 13 (Fig. 2E and 2F).
The effect of intrathecal administration of a general 
inhibitor of PP2A on exploratory behavior
OA, a nonselective inhibitor of PP2A and PP1, was given
intrathecally in a group of seven rats. Fig. 3 demonstrates
that administration of OA had no effect on the spontane-
ous exploratory activity of the rats. None of the activity
parameters in OA-administered rats, such as total activity
(1628 ± 170), distance traveled (596 ± 40), active time
(1603 ± 76), resting time (1097 ± 76), rearing time (373
± 58), and rearing events (198 ± 18) in consecutive 45-
minute intervals was significantly different when com-
pared to the intrathecally implanted group.
Decreased exploratory activity induced by capsaicin was 
potentiated by intrathecal administration of PP2A 
inhibitors
The bar graphs in Fig. 4 show the effects of PP2A inhibi-
tors on the spontaneous exploratory activity of rats fol-
lowing capsaicin injection. Reduced exploratory behavior
induced by capsaicin was aggravated by both the general
inhibitor of PP1 and PP2A, OA, and the specific inhibitor
of PP2A, fostriecin.
Three groups of rats were used in this experiment. Pre-
treatment with ACSF administered through the intrathe-
cal catheter (n = 7) was done in the control group; OA (n
= 9) or fostriecin (n = 5) was administered in the two
experimental groups. Thirty minutes after the pretreat-
ment with drugs infused through the intrathecal catheter,
capsaicin was injected intradermally in the left hind paw
of the rats. Animals were put into an activity chamber 30
min after the injection to monitor the movements.
Spontaneous exploratory activity in rats with OA pretreat-
ment was greatly affected compared to the control group.
Total activity significantly decreased from 1123 ± 160 to
570 ± 89; consequently the distance traveled decreased
greatly from 426 ± 41 to 225 ± 37; active time decreased
from 1200 ± 97 to 797 ± 123; and the resting time
increased from 1500 ± 97 to 1903 ± 123 in consecutive
45-minute intervals. Rearing time in the OA group was
also reduced greatly from 193 ± 26 to 39 ± 9, and the rear-
ing events were reduced from 125 ± 33 to 36 ± 9. The
measurements in the fostriecin-pretreated group were also
significantly reduced compared to the control. For com-
parison, the total activity, distance traveled, active time,
resting time, rearing time, and rearing events in fostriecin
group were 674 ± 73, 286 ± 28, 900 ± 60, 1800 ± 60, 65 ±
21, 60 ± 18 respectively.
The line graphs in Fig. 5 demonstrate the changes in
exploratory behavior at each 5-min interval. When rats
were placed in a novel environment, the spontaneous
exploratory activity was high initially and slowly declined
over the first 30 min. The activity in all groups of rats in
the current study showed this same temporal pattern. The
total entries, distance traveled, active time, rearing time,
and rearing events were high in the first 20–25 min and
then declined. In the groups treated with PP2A inhibitors,
the exploratory activity was decreased compared with the
ACSF-treated group. This reduction lasted throughout the
45-min block.
Discussion
The results of this study showed that PP2A in the spinal
cord plays an important role in the signal cascades that are
activated following intradermal injection of capsaicin in
the hind paw of rats. Based on the data presented, expres-
sion of PP2A in the spinal cord of rat starts to increase by
15 minutes after capsaicin injection and starts to return to
baseline by about 1 hour.
With capsaicin injection, the spontaneous exploratory
activity of rats was significantly reduced due to nocicep-
tion. Following the injection, the number of rearing
events and the rearing time were decreased. Measures of
active time, total entries, and distance traveled were also
decreased despite the fact that hind limb locomotor func-
tion was not impacted. In this model, secondary mechan-
ical allodynia and hyperalgesia and primary thermal
hyperalgesia would have occurred following capsaicin
injection. So, during the process of central sensitization, a
concurrent decrease in exploratory behavior would be
expected, as seen in the current study. The reduction in
exploratory activity seen in our model is in agreement
with previous reports of exploratory behavior in other
pain models. Palecek et al. [15] found a decrease in
exploratory behavior following pain induced by colonMolecular Pain 2006, 2:9 http://www.molecularpain.com/content/2/1/9
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Effect of intrathecal infusion of the phosphatase inhibitors okadaic acid and fostriecin, or ACSF on decreased exploratory activ- ity induced by capsaicin (0 Figure 5
Effect of intrathecal infusion of the phosphatase inhibitors okadaic acid and fostriecin, or ACSF on decreased exploratory activ-
ity induced by capsaicin (0.1%, 50 µl) injection. Thirty min after capsaicin injection, okadaic acid (20 nM), fostriecin (30 nM), or 
ACSF was infused into the subarachnoid space of the spinal cord at the L5 segmental level of the rats. Compared to ACSF (n = 
7), six parameters of spontaneous activity of the rats with okadaic acid (n = 7) and fostriecin (n = 5) infusion showed a signifi-
cant decrease at every time interval. Each point represents the mean ± S.E.M. *p < 0.05.
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inflammation and distention. Zhang et al. [16] showed
reduced exploratory behavior in a model of pancreatitis.
The decrease of movement with a normal ability to move
results in less active time and more resting time, implying
the development of pain following capsaicin injection.
Intrathecal administration of PP2A inhibitors signifi-
cantly aggravates pain, leading to a decrease in the total
activity, traveled distance, active time, rearing time, rear-
ing events, and an increase in the resting time of rats.
PP2A expression in the spinal cord after noxious stimuli
Intradermal injection of capsaicin is a useful and reversi-
ble experimental model for the study of an inflammatory
pain state that includes hyperalgesia and allodynia [17-
20]. In the capsaicin model, central sensitization can be
initiated by neural activity originating in the area of injec-
tion and carried by chemosensitive afferent fibers. The
whole process relies on central pain mechanisms. It occurs
after prolonged C-nociceptor input and depends on acti-
vation of wide dynamic range neurons in the dorsal horn
of the spinal cord [21,22]. During central sensitization, a
variety of signal transduction pathways in central neurons
are activated, through which the excitability of central
neurons is enhanced. It has been demonstrated that pro-
tein kinase C, NO/protein kinase G, protein kinase A, and
calcium/calmodulin dependent kinase II (CaMKII) are all
involved in this process. In addition, several types of iono-
tropic glutamate receptors become phosphorylated dur-
ing central sensitization [20,23-31].
In this study, 15 minutes after capsaicin injection into the
hind paw of rats, PP2A expression in the spinal cord is
upregulated compared with the control group with a vehi-
cle injection. In such a the short time period, the increased
expression may not only reflect an increase of PP2A pro-
tein synthesis but also the posttranslational modification
of PP2A subunits. The catalytic subunits of PP2A (PP2Ac)
can be regulated mainly by three posttranslational modi-
fications: methylation, phosphorylation of tyrosine and
phosphorylation of threonine. By these modifications,
PP2A activity and function can be regulated [32]. The anti-
body that we used in the Western Blot study recognizes
the PP2A at 36 KDa, and it preferentially recognizes
demethylated PP2A. This suggests that the increased PP2A
expression may partly reflect an increased demethylation
of PP2A.
The increased PP2A protein expression peaked at 30 min
and it continued at least through 1 h following intrader-
mal injection of capsaicin. This suggests that PP2A may
also be involved in central sensitization after intradermal
injection of capsaicin through modulation of the phos-
phorylation state of some critical proteins in the spinal
cord.
Capsaicin injection reduces exploratory activity of rats
In the present study, an automated photobeam activity
system was used to test the rodent exploratory activity to
evaluate behavioral changes induced by intradermal
injection of capsaicin. The activity system was a useful
tool for measurement of the exploratory activity for com-
parisons of control rats and rats with noxious stimulation
of peripheral tissues, with or without pharmacological
treatments. Capsaicin injection reduced the exploratory
activity of rats by decreasing the total activity, traveled dis-
tance, active time, rearing time, and rearing events, while
increasing the resting time in a 45-min period. Intrader-
mal injection of capsaicin is a noxious stimulus that
evokes not only ongoing pain (which lasts for about 15–
20 minutes), but also a pain state in which there is
increased sensitivity to mechanical stimuli. Intradermal
injection of capsaicin can cause changes in behavioral
responses of rats and increase responses of nociceptive
projection neurons in dorsal horn of the spinal cord at a
cellular level [15,17-20,22]. In our experiment, the
exploratory activity of animals was tested 30 min after
capsaicin injection. The changes of activity reflect the pain
induced by mechanical stimulation of the paw during
movement in the activity chamber instead of the pain
evoked directly by the intradermal injection. In previous
studies in our laboratory, intradermal injection of capsai-
cin did not cause any systemic effect, and the handling of
rats during the injection had no effect [15]. On the other
hand, the exploratory activity was not affected by the
sham injection of vehicle (data not shown), which is con-
sistent with the results of Palecek et al. [15]. The behavio-
ral changes in exploratory activity are presumably due to
nociceptive signals induced by capsaicin injection, and
the changes reflect primary and/or secondary mechanical
allodynia and hyperalgesia.
PP2A inhibitors potentiate the reduction of exploratory 
activity that is induced by capsaicin injection
In the present study, PP2A inhibitors, either OA or fos-
triecin, did not themselves reduce the exploratory activity
of the animals. On the other hand, pretreatment with
PP2A inhibitors through an intrathecal catheter extended
the duration of the decreases of the behavior induced by
capsaicin. This suggests that without the peripheral nox-
ious stimuli, the reactions that PP2A modulated would
not initiate central sensitization directly, but they may be
involved in the process of central sensitization by limiting
the duration of this process.
It is well known that protein phosphatases function as key
molecules in essential regulatory mechanisms in many
cellular processes. Serine/threonine protein phosphatases
remove phosphate groups from either serine or threonine
sites following phosphorylation of target proteins and
thus reverse protein phosphorylation [1,5,6,8,33,34].Molecular Pain 2006, 2:9 http://www.molecularpain.com/content/2/1/9
Page 9 of 12
(page number not for citation purposes)
Since protein dephosphorylation is an essential post-
translational regulatory mechanism in signal transduction
in the central nervous system that reverses the process of
protein phosphorylation, protein phosphatases which
mediate this process have gained more attention because
their role in regulating protein phosphorylation is as
important as that of protein kinases. PP2A is one of the
most important protein phosphatases in the central nerv-
ous system, and it can regulate the activities of many
kinases both in vivo and in vitro, such as ERK/MAPKs, PKA,
PKC, IKB kinase, and Ca/calmodulin-dependent kinase
[35-37]. Currently, glutamate receptors have become a
main focus in pain research. The increases in responsive-
ness of dorsal horn neurons to mechanical stimulation of
the skin after intradermal injection of capsaicin are due in
part to the upregulation of phosphorylated glutamate
receptors by a variety of protein kinases [38-41]. Our cur-
rent findings of the effect of PP2A inhibitors on capsaicin-
induced central sensitization suggest that PP2A has an
effect on the duration of central sensitization. Although
the mechanism is unclear, it may partially relate to the
modulation of the phosphorylation of glutamate recep-
tors, or regulation of the function of protein kinases by
PP2A.
Methods
Experimental animals
Male Sprague-Dawley rats weighing 250–300 g were used
in this study. The protocols for these experiments were
approved by the Institutional Animal Care and Use Com-
mittee. These experimental protocols were also consistent
with the ethical guidelines of the National Institutes of
Health and the International Association for the Study of
Pain. All animals used in the experiments were housed
and maintained in accordance with the guidelines of the
University of Texas Medical Branch (UTMB) Animal Care
and Use Committee (ACUC).
Intrathecal catheter implantation
The intrathecal catheters were made by joining three pol-
yethylene tubes of different diameters and had a total
length of 16 cm. The smallest diameter PE32 tubing (7.3–
7.5 cm in length) (MICOR Inc., PA, USA) was inserted
into the subarachnoid space of the spinal cord. The other
end was connected with PE10 (3 cm) and then PE20 (8
cm) tubing (Becton Dickson, MD, USA) for a stepdown
connection to a Hamilton syringe. Each joint of the cath-
eter was sealed with epoxy glue. The catheter was dried,
sterilized by immersion in 70% ethanol before insertion,
and fully flushed with sterile saline prior to use. A length
of stainless steel wire, whose diameter just fit into the
PE32 tubing, was used during insertion.
Rats used in behavioral tests were anesthetized with
sodium pentobarbital (50 mg/kg i.p.). The intrathecal
catheter was inserted into the subarachnoid space of the
spinal cord for the administration of drugs at the L5 seg-
mental level according to the protocol of Yaksh et al. [42]
as modified by LoPachin and Rudy [43]. To implant a
catheter, the anesthetized rat was mounted in a stereotaxic
instrument to hold the rat's head firmly. A midline inci-
sion was made beginning at a line joining the ears and
extending about 2 cm in a caudal direction. The fascia was
retracted from the skull. A superficial layer of neck mus-
cles was exposed by the initial incision of the skin, and the
muscles were separated by a midline incision beginning at
the occipital crest and extending caudally about 2 cm. The
separation of the superficial musculature exposed an
underlying layer of muscles which could be easily sepa-
rated along the midline by blunt dissection. Then, the
muscles were freed from their point of origin on the occip-
ital bone for about 0.5 cm on either side of the midline by
using a scraping tool. While observing the back of the
skull, the neck musculature was gently retracted and the
atlanto-occipital membrane was exposed. In the midline,
a small incision was made through the atlanto-occipital
membrane, using the tip of a fresh 18- or 20-ga disposable
needle as a cutting edge. Once the membrane was pierced,
there was ample outflow of clear cerebrospinal fluid. The
correct incision had to be carried out with considerable
care to prevent cutting the dorsal surface of the medulla,
which lies immediately beneath the membrane. The cath-
eter was carefully advanced 7.3–7.5 cm into the spinal
subarachnoid space from the incision. The tip of the cath-
eter was placed at the T12-L1 vertebral level, which was
estimated to be the L4/5 level of the spinal cord. When the
catheter had been advanced 1–2 cm, a slight tension was
applied to the tail of the animal to keep the animal's spine
straight for the rest of the insertion. Once the catheter was
inserted, the incision was sutured and the animal returned
to the Animal Care Facility for 5 days to allow it to recover
from the surgical procedure. The awake animals
implanted with a catheter were checked for motor or sen-
sory deficits after recovery. Animals with any sign of defi-
cits were discarded.
Administration of drugs
The drugs used in these experiments were serine/threo-
nine protein phosphatase inhibitors: okadaic acid, a gen-
eral inhibitor of PP2A and PP1 (20 nM, Calbiochem,
dissolved in ACSF) and fostriecin, a potent PP2A inhibitor
(30 nM, Calbiochem, dissolved in ACSF). Concentrations
of these drugs were based on published dose response
curves [44-46].
All drugs were administered through an intrathecal cathe-
ter implanted into the subarachnoid space of the spinal
cord 30 minutes before injection of capsaicin. Drugs for
intrathecal injection were dissolved in a 10 µl volume of
ACSF containing the desired concentration of the agent.Molecular Pain 2006, 2:9 http://www.molecularpain.com/content/2/1/9
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All drugs were injected over a 1–2 minute time period. A
10 µl injected volume has been shown to spread 2 cm ros-
tral and caudally [42]. After intrathecal drug injection, the
catheter was flushed with a subsequent 10 µl injection of
ACSF. A Hamilton microinjection syringe (10 µl, Hamil-
ton Co., Reno, NV) was used for all injections.
Injection of capsaicin
Capsaicin (1%, 50 µl) was injected into the plantar surface
of the glabrous skin of the left paw of halothane anesthe-
tized rats [15]. Capsaicin was dissolved in Tween 80 (7%),
alcohol (20%), and saline.
Western blotting
Animals used in the Western immunoblotting study were
deeply anesthetized with sodium pentobarbital (50 mg/
kg, i.p.). The spinal cord was removed quickly at different
timepoints after intradermal injection of capsaicin or
vehicle. Laminectomy was done and the ipsilateral dorsal
spinal cord tissue was placed in liquid nitrogen immedi-
ately and homogenized in 50 mM Tris buffer, pH 7.4 (0.1
mol/l EGTA, 0.14 µl/ml β-mercaptoethanol, 100 mol/l
PMSF, and 0.2 mg/ml trypsin inhibitor). The homogenate
was centrifuged at 13,000 g for 15 minutes, and the super-
natant was decanted from the pellet and used for Western
blot analysis. The concentration of protein in the
homogenate was measured using a BCA kit (Pierce, Rock-
ford, IL). Equal amounts of protein (60 µg) were size frac-
tionated by 7.5% (w/v) sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and
transferred onto a PVDF membrane (Bio-Rad, Hercules,
CA). After blocking in the blocking buffer for 1 hour at
room temperature, the blots are incubated with primary
antibody for 1 hour at room temperature. The primary
antibody to PP2A was monoclonal from Upstate (Char-
lottesville, VA) and primary antibody to β-actin was from
Sigma (St. Louis, MO). Then the blots were washed three
times for 30 minutes each in washing buffer and incu-
bated with horseradish peroxidase conjugated IgG diluted
in 2.5% (w/v) non-fat milk in washing buffer. The mem-
branes were washed with buffer three times for 30 min-
utes and enhanced with a chemiluminescence reagent
(ECL kit, Amersham, Arlington Heights, IL). Then the
blots were exposed to autoradiographic film (Kodak,
Rochester, NY), and the intensity of specific immunoreac-
tive bands was quantified using densitometric scanning
analysis. Densitometric units of specific bands were
expressed relative to the values of background units. The
relative density of the immunoblots from the spinal cord
tissue of rats with injection of vehicle or capsaicin was cal-
culated by dividing the density of the PP2A blots by the
density of β-actin blots for the same conditions.
Behavioral tests
The exploratory activity of the animals was recorded 5
days after intrathecal catheter implantation. For monitor-
ing movements, two activity chambers (40 × 40 × 40 cm)
were used and the data for motor activity were collected in
the clear plastic chambers and analyzed using the software
and hardware provided by the Photobeam Activity System
(PAS) with Flexfield (San Diego Instruments, Inc.) cou-
pled to a 486 Compaq computer. The PAS allows moni-
toring of the exploratory activity within the chamber by
detecting the number of times photobeams are inter-
rupted in an x, y, and z axis oriented grid system. There are
16 photobeams on each horizontal axis, which are
arranged 4 cm above the chamber floor. Obstruction of
these beams can be recorded as movements in the x and y
planes. Movements along the z axis, which are called rear-
ing events, can be detected by another set of beams
located 12 cm above the chamber floor. When the animal
remains still for 1 second or longer, this is defined as rest-
ing time. There are six different behavioral measures of
exploratory activity to be recorded: the number of beams
broken (counts), traveled distance, active time, resting
time, rearing events, and rearing time. Since changes in
one parameter are not reflected in every other parameter,
the changes are evaluated for each parameter individually.
The activity of each animal is recorded over nine consecu-
tive 5-minute intervals for a total of 45 minutes. All the
animals are tested at the same time during the day in a
separate room where no people or other animals are
present. The room is controlled at a stable temperature
(70–72°F) and low level of noise. The animals are
brought into the room just before the test, and the room
is dark during the test. Between tests, the enclosure is
cleaned with Cavicide and alcohol to eliminate urine and
other olfactory cues from previous animals [15,16,47].
Statistical analysis
The relative densities of Western blots from the tissue of
the lumbar segments of rats at different time points (5
min, 15 min, 30 min, 60 min, and 90 min) were com-
pared between vehicle and capsaicin groups. One-way
ANOVA was performed followed by post hoc compari-
sons using Student-Newman-Keuls multiple comparisons
test. All values are presented as mean ± S.E.M. A p value of
less than 0.05 was considered significant.
All six activity measures were compared during the 45-
min interval. Rats of the naïve group and intrathecal injec-
tion group were compared with Student's t-test. Student's
t-test was also used to compare the responses of rats in the
capsaicin group and the vehicle group. One-way ANOVA
was performed to assess behavioral changes followed by
post hoc comparisons using Student-Newman-Keuls mul-
tiple comparisons test. All treatment groups with capsai-
cin injection were compared to vehicle-treated rats. AllMolecular Pain 2006, 2:9 http://www.molecularpain.com/content/2/1/9
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data were expressed as mean ± S.E.M. A p value of less than
0.05 was considered significant.
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